Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C
(1994) In Journal of Clinical Investigation 94(6). p.2521-2524- Abstract
Resistance to activated protein C (APC) is the most prevalent inherited cause of venous thrombosis. The APC resistance phenotype is associated with a single point mutation in the factor V gene, changing Arg506 in the APC cleavage site to a Gln. We have investigated 50 Swedish families with inherited APC resistance for this mutation and found it to be present in 47 of them. Perfect cosegregation between a low APC ratio and the presence of mutation was seen in 40 families. In seven families, the co-segregation was not perfect as 12 out of 57 APC-resistant family members were found to lack the mutation. Moreover, in three families with APC resistance, the factor V gene mutation was not found, suggesting another still unidentified cause of... (More)
Resistance to activated protein C (APC) is the most prevalent inherited cause of venous thrombosis. The APC resistance phenotype is associated with a single point mutation in the factor V gene, changing Arg506 in the APC cleavage site to a Gln. We have investigated 50 Swedish families with inherited APC resistance for this mutation and found it to be present in 47 of them. Perfect cosegregation between a low APC ratio and the presence of mutation was seen in 40 families. In seven families, the co-segregation was not perfect as 12 out of 57 APC-resistant family members were found to lack the mutation. Moreover, in three families with APC resistance, the factor V gene mutation was not found, suggesting another still unidentified cause of inherited APC resistance. Of 308 investigated families members, 146 were normal, 144 heterozygotes, and 18 homozygotes for the factor V gene mutation and there were significant differences in thrombosis-free survival curves between these groups. By age 33 yr, 8% of normals, 20% of heterozygotes, and 40% of homozygotes had had manifestation of venous thrombosis.
(Less)
- author
- Zöller, Bengt LU ; Svensson, P J LU ; He, X and Dahlbäck, Björn LU
- organization
- publishing date
- 1994-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- blood coagulation, factor V, protein C, protein S, thrombophilia, blood clotting factor 5, article, blood clotting, blood clotting disorder, controlled study, female, gene mutation, human, major clinical study, male, point mutation, priority journal, vein thrombosis
- in
- Journal of Clinical Investigation
- volume
- 94
- issue
- 6
- pages
- 4 pages
- publisher
- The American Society for Clinical Investigation
- external identifiers
-
- pmid:7989612
- scopus:0028037137
- ISSN
- 0021-9738
- DOI
- 10.1172/JCI117623
- language
- English
- LU publication?
- yes
- id
- a5e57d85-5750-4a1c-9ff1-5b9804ff72f0
- date added to LUP
- 2017-10-19 16:35:33
- date last changed
- 2024-06-25 06:37:41
@article{a5e57d85-5750-4a1c-9ff1-5b9804ff72f0, abstract = {{<p>Resistance to activated protein C (APC) is the most prevalent inherited cause of venous thrombosis. The APC resistance phenotype is associated with a single point mutation in the factor V gene, changing Arg506 in the APC cleavage site to a Gln. We have investigated 50 Swedish families with inherited APC resistance for this mutation and found it to be present in 47 of them. Perfect cosegregation between a low APC ratio and the presence of mutation was seen in 40 families. In seven families, the co-segregation was not perfect as 12 out of 57 APC-resistant family members were found to lack the mutation. Moreover, in three families with APC resistance, the factor V gene mutation was not found, suggesting another still unidentified cause of inherited APC resistance. Of 308 investigated families members, 146 were normal, 144 heterozygotes, and 18 homozygotes for the factor V gene mutation and there were significant differences in thrombosis-free survival curves between these groups. By age 33 yr, 8% of normals, 20% of heterozygotes, and 40% of homozygotes had had manifestation of venous thrombosis.</p>}}, author = {{Zöller, Bengt and Svensson, P J and He, X and Dahlbäck, Björn}}, issn = {{0021-9738}}, keywords = {{blood coagulation; factor V; protein C; protein S; thrombophilia; blood clotting factor 5; article; blood clotting; blood clotting disorder; controlled study; female; gene mutation; human; major clinical study; male; point mutation; priority journal; vein thrombosis}}, language = {{eng}}, number = {{6}}, pages = {{2521--2524}}, publisher = {{The American Society for Clinical Investigation}}, series = {{Journal of Clinical Investigation}}, title = {{Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C}}, url = {{http://dx.doi.org/10.1172/JCI117623}}, doi = {{10.1172/JCI117623}}, volume = {{94}}, year = {{1994}}, }